ALLISON MALESKI: Open Payments
NPI 1891404018 · KING OF PRUSSIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$660 in 30 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $101 · 2025 $660
Food & beverage: $660
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $224 |
| UCB, Inc. | 3 | $84 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
| ABBVIE INC. | 3 | $57 |
| GENZYME CORPORATION | 2 | $38 |
| Incyte Corporation | 1 | $29 |
| Almirall LLC | 1 | $28 |
| Lilly USA, LLC | 1 | $27 |
| Arcutis Biotherapeutics, Inc. | 1 | $23 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $22 |
Products named: TREMFYA, Bimzelx, LIBTAYO, SKYRIZI, DUPIXENT, OPZELURA, Seysara, EBGLYSS.
Industry payments across PA — which companies pay providers there.
